Just last week, the Food and Drug Administration (FDA) approved a new epinephrine auto-injector, Symjepi.
I don’t much like the name, but if it’s cheaper…!
I’ve posted several times about the skyrocketing cost of EpiPens—over 500% in the last 10 years.
Anyone who, like me, has been shocked at the pharmacy to discover how much a two-pack of EpiPens costs will be hoping Symjepi will be more affordable.
It won’t be available on the market until later this year, so I don’t know yet how much it will cost. But Adamis Pharmceuticals, the company that makes Symjepi, stated in a press release:
We want to position this product as a low-cost alternative to the other current offerings in the anaphylaxis market.
Of course, it’s all a bit relative. EpiPens cost around $700 per two-pack (which is crazy because the injectors only cost about $20 to make), but what you actually pay depends in large part on your health insurance plan—if you have insurance.
I will be really disappointed if Symjepi ends up costing more than $100 out of pocket for anyone without insurance. Otherwise, it will just be another high-priced drug that we can’t afford.
Mylan, the makers of EpiPens, made a big deal about their generic version that was introduced late last year. But at $300 for a pair of injectors, that’s still too expensive, imho.
I do like that Symjepi will be available as a single injector, while EpiPens only come in packs of two.
And I like the design—it’s shorter and has a grip that could make giving the injection easier. It’s sturdier, too, so I can see people being able to carry it around in a backpack or purse without worrying it will break.
I’ll write another post as soon as Symjepi is available and I know what it costs! Stay tuned.